A new tool to find targets for pediatric brain tumor treatments
The TAPESTRY web application catalogs thousands of splicing events to help find new therapeutic targets.
Researchers built TAPESTRY, a database and web application. It helps people explore tumor-enriched splice junctions (TEJs) in pediatric brain tumors.
The tool catalogs 45,430 recurrent TEJs across 19 histologies. These were identified from 1,962 RNA-seq specimens, including 1,272 independent primary tumors.
A splice junction is a connection between parts of a gene. These junctions are compared to four normal brain reference cohorts. These cohorts include adult, pediatric, developmental, and cell-type-resolved tissue.
Each junction is classified as tumor-specific or oncofetal. Users can search by gene or splicing event and filter results by histology or junction class.
The tool supports the prioritization of splice-derived targets. These targets are for antibody-based, cell-based, and vaccine immunotherapies in pediatric brain and central nervous system tumors.
Key facts
- TAPESTRY catalogs 45,430 recurrent tumor-enriched splice junctions.
- The data includes 1,962 RNA-seq specimens from the Pediatric Brain Tumor Atlas.
- The tool helps find targets for antibody-based, cell-based, and vaccine immunotherapies.